Heart-lung Machine Market Size, Share, Opportunities, And Trends By Component (Oxygenators, Pumps, Cannula, Monitoring Systems, Heat Exchanger Units, Others), By Application (Heart Valve Surgeries, Heart Transplant, Lung Transplant, Others), By End-User (Hospitals, Clinics, Others), And By Geography - Forecasts From 2023 To 2028

  • Published : Aug 2023
  • Report Code : KSI061615963
  • Pages : 128

The heart-lung machine market was valued at US$690.001 million in 2021.

A heart-lung machine, often known as a cardiopulmonary bypass (CPB) machine, is necessary for open-heart surgery. It temporarily takes over the roles of the heart and lungs, enabling surgeons to do surgery on a heart that is still and bloodless. A pump, oxygenator, and monitoring systems make up the apparatus. Blood is re-oxygenated after being redirected away from the heart and lungs. The pump pumps blood while the oxygenator removes carbon dioxide and supplies oxygen. With the ability to repair damaged hearts, this ground-breaking technology has revolutionised cardiac surgery, enabling intricate treatments and saving many lives.

Heart-lung machine market growth prospects

The global increase in the incidence of cardiovascular disorders is a primary driver of the heart-lung machine market because it raises demand for cardiac surgeries and other operations that need the use of heart-lung machines. Technology developments and the ongoing creation of novel systems are propelling heart-lung machine market growth as they raise the efficacy, efficiency, and safety of these devices. Additionally, favourable reimbursement policies, rising healthcare costs, and increased knowledge of cutting-edge heart disease treatments are driving heart-lung machine market share. The demand for heart-lung machines is also fueled by the ageing population and the associated rise in age-related cardiac conditions.

An increasing number of cardiovascular surgeries

Cardiac surgery is the highest market share holder for the heart-lung machine market. The frequency of cardiovascular disorders is rising globally, which has increased the need for cardiac procedures, among other variables that contribute to its dominant position. These operations need the use of heart-lung machines because they give the required support to momentarily replace the functions of the heart and lungs. The range of cardiac operations has increased as a result of improvements in surgical methods and technology and now includes intricate procedures like coronary artery bypass grafting (CABG), valve repair/replacement, and heart transplants. Heart-lung devices are frequently used during these surgeries to assure patient security and excellent outcomes.

Continuous technological advancements

Open heart surgery perfusion technology has seen significant developments recently, which is a key industry trend anticipated to support heart-lung machine market growth. The heart-lung machine market share is projected to be driven by the significant uptake of cutting-edge diagnostic technologies for cardiovascular illnesses. Increased use of improved temperature control techniques, such as cardiopulmonary bypass and hypothermia, in open heart surgery is projected to present large growth potential for heart-lung machine market players.

Increase in demand for open-heart surgeries

The focus on open-heart surgery risks by healthcare professionals is projected to increase demand for heart-lung machines. For instance, recent advances in cardiopulmonary bypass procedures used for neonatal and infant cardiac surgery are expected to lead to new business prospects for firms operating in the worldwide heart-lung machine market. Other examples include expanding the use of improved myocardial protection circuits in mitral valve repair and aortic valve replacement, as well as the creation of a new generation of priming options for cardiopulmonary bypass circuits.

Increasing use of portable heart-lung machine

Compared to traditional heart-lung machines, portable heart-lung machines are lighter and take up less area in operating rooms. However, these devices are more costly than standard heart-lung machines. Vendors have created portable heart-lung machines that may run on a rechargeable battery and be transferred to any location within the hospital to lessen the cost strain on hospitals. In an ambulatory context or operating rooms, these portable machines assist doctors in providing extracorporeal circulation to patients who are at a critical stage during any emergency time which is further fueling the heart-lung machine market growth.

The European heart-lung machine market is anticipated to grow

During the projected period, the heart-lung machine market share is expected to expand significantly in Europe. The demand for cardiac operations and treatments requiring heart-lung machines is driving this development, which is attributed to the rising prevalence of cardiovascular disorders. The healthcare system in Europe is well-established, with cutting-edge facilities and knowledgeable healthcare workers, creating a favourable atmosphere for the adoption of cutting-edge medical innovations. Additionally, rising expenditures on cardiac care-related research and development as well as the launch of novel heart-lung machine systems are anticipated to drive the heart-lung machine market expansion. Furthermore, it is projected that the heart-lung machine market growth in Europe will be fueled by helpful government efforts, encouraging reimbursement policies, and an increase in the number of elderly people.

Increased medical tourism in Asia

The demand for cardiac procedures has grown due to the incidence of CVDs (cardiovascular illnesses) in Asia and the changing lifestyles of growing nations like China and India. The main factors enticing tourists from abroad to travel to Asian nations are the rise in healthcare spending, an increase in hospitals, better healthcare facility infrastructure, accessibility to highly skilled medical professionals, and rising affordability of overall healthcare services. In comparison to industrialised nations throughout North America and Europe, these nations provide cutting-edge medical procedures at significantly lower charges. Patients from affluent nations like the UK, Canada, and the US seek out the inexpensive healthcare treatments offered in Asia.

Market players strategies

To innovate technologically advanced items, heart-lung machine market participants are increasing their spending in R&D initiatives. The tactic is assisting them in gaining a competitive advantage over rivals. The approval of devices that can aid in challenging paediatric and adult cardiopulmonary bypass procedures is the focus of several businesses.

Several businesses are working with the government and healthcare institutions to encourage the adoption of sophisticated surgical instruments. These initiatives have resulted in the creation of modular heart-lung devices that are affordable, secure, and easy to operate. In addition, since these devices are portable and run on rechargeable batteries, they give doctors more freedom. CPB pumps have also undergone a number of upgrades from the manufacturers to stop blood from being overoxygenated.

Market Key Developments

  • In March 2023, LivaNova's Essenz heart-lung machine (HLM) has been given 510(k) approval by the US Food and Drug Administration (FDA) for use in cardiopulmonary bypass (CPB) surgeries.
  • In September 2022, during a visit to The Alfred Precinct on World Heart Day, the Hon Mark Butler, Minister for Health and Aged Care, was joined by local MPs Josh Burns and Dr. Michelle Ananda-Rajah to announce the $999,779.40 Medical Research Future Fund (MRFF) Cardiovascular Health Mission award.



  • By Component
    • Oxygenators
    • Pumps
    • Cannula
    • Monitoring Systems
    • Heat Exchanger Units
    • Others
  • By Application
    • Heart Valve Surgeries
    • Heart Transplant
    • Lung Transplant
    • Others
  • By End-User
    • Hospitals
    • Clinics
    • Others
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Indonesia
      • Thailand
      • Others


1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline


2.1. Research Data

2.2. Assumptions


3.1. Research Highlights


4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis


5.1. Introduction

5.2. Oxygenators

5.3. Pumps

5.4. Cannula

5.5. Monitoring Systems

5.6. Heat Exchanger Units

5.7. Others


6.1. Introduction

6.2. Heart Valve Surgeries

6.3. Heart Transplant

6.4. Lung Transplant

6.5. Others


7.1. Introduction

7.2. Hospitals

7.3. Clinics

7.4. Others


8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Spain

8.4.5. Others

8.5. The Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others


9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix


10.1. Soma Technology

10.2. Senko Medical Instrument 

10.3. Heart Care India Co.

10.4. Mat Medical Systems

10.5. Terumo Europe

10.6. Terumo Cardiovascular

10.7. Medinnova

10.8. LivaNova

10.9. Aussin Intensive Care

10.10. Verywell Health

Soma Technology

Senko Medical Instrument 

Heart Care India Co.

Mat Medical Systems

Terumo Europe

Terumo Cardiovascular



Aussin Intensive Care

Verywell Health